State Of Wyoming Relmada Therapeutics, Inc. Transaction History

State Of Wyoming

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$16.5 - $30.34 $165 - $303	10 Added 31.25%	42 $1,000
Q1 2022 May 13, 2022	BUY	$16.72 - $26.99 $535 - $863	32 New	32 $1,000
Q4 2021 Feb 11, 2022	SELL	$16.93 - $26.82 $84 - $134	-5 Closed	0 $0
Q3 2021 Feb 11, 2022	BUY	$21.86 - $34.77 $109 - $173	5 New	5 $0

12.3M

229K

138K

Ticker RLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,608,500
Market Cap $11.7M
Description
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system (CNS) diseases and other disorders. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a new chemical entity and N-methyl-D-aspartate receptor antagonist that ...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.